Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neuromuscular electrical stimulation cycling exercise for persons with advanced multiple sclerosis.
T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1.
A common anesthesiology procedure for a patient with an uncommon combination of diseases: a case report.
Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques.
Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors.
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats.
Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: A randomised controlled feasibility study.
Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.
Economic impact of multiple sclerosis in Italy: focus on rehabilitation costs.
Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches.
RP-CARS: label-free optical readout of the myelin intrinsic healthiness.
The Immune Pathogenesis of Multiple Sclerosis.
Biogen Reports Top-Line Results from Phase 3 Study Evaluating Natalizumab in Secondary Progressive MS
Optic neuritis revealing Kikuchi-Fujimoto disease.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
Oxidative stress and neurodegenerative disease.
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
Modulating effects of WT1 on interferon-β-vitamin D association in MS.
GABA transport and neuroinflammation are coupled in multiple sclerosis: Regulation of the GABA transporter-2 by ganaxolone.
New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease.
Role of toll-like receptor 2 in ischemic demyelination and oligodendrocyte death.

Pages